期刊文献+

检测尿B型利钠肽在心力衰竭诊断中的意义 被引量:4

Significance of Urinary B-type Natriuretic Peptide Assay for the Diagnosis of Heart Failure
暂未订购
导出
摘要 目的本研究的目的是探索尿BNP与血浆BNP是否存在相关性,及其在心力衰竭中是否有诊断价值。方法本研究纳入45例心力衰竭患者及25例健康对照组。检测尿BNP和血浆BNP。对心力衰竭患者进行心功能分级。结果心力衰竭组尿液BNP均值为154.5±82.1pg/ml,对照组为24.8±9.0pg/ml,两组间有明显差异(P=0.000)。尿液BNP和血浆BNP、心功能分级存在相关性。尿液BNP的截点值为34.5pg/ml时,其特异性和敏感度分别为88.9%和92.0%。结论尿液BNP检测有助于诊断心力衰竭及判断心力衰竭的严重程度。 Objective To evaluate the value of urinay B Type natriuretic peptide (BNP) in the diagnosis of heart failure, and study the correlation between urinary BNP and plasma BNP. Methods We studied 45 patients with heart failure and 25 healthy controls. All the patients' and controls' urinary and plasma were detected. The patients' heart function was classified according to NYHA system. Results Average urinary BNP Ievels were 154.5 ± 82. lpg/ml in heart failure group and 24.8 ±9. Opg/ml in the controls ( t = 7.52, P 〈 0. 0001 ). Urinary BNP was correlated with plasma BNP and NYHA grades of heart failure. The optimal cutoff value for urinary BNP was 34.5pg/ml. Its specificity and sensitivity were 88.9% and 92.0% , respectively. Conclusion Measurement of urinary BNP is applica- ble in clinical diagnosis of heart failure and judgement of heart function.
出处 《医学研究杂志》 2013年第1期162-166,共5页 Journal of Medical Research
关键词 B型利钠肽 心力衰竭 尿液 B - type natriuretic peptide Heart failure Urine
  • 相关文献

参考文献11

  • 1Christenson RH,Azzazy HM,Duh SH. Impact of increased body mass index on accuracy of B-type natriuretic peptide(BNP)and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality[J].Clinical Chemistry,2010,(04):633-641.
  • 2O'Donoghue M,Braunwald E. Natriuretic peptides in heart failure:should therapy be guided by BNP levels[J].Nat Rev Cardiol,2010,(01):13-20.
  • 3Macabasco-O'Connell A,Meymandi S,Bryg R. B-type natriuretic peptide (BNP) is useful in detecting asymptomatic left ventricular dysfunction in low-income,uninsured patients[J].BIOLOGICAL RESEARCH FOR NURSING,2010,(03):280-287.
  • 4Clerico,Fontana M,Ripoli A. Clinical relevance of BNP measurement in the follow-up of patients with chronic heart failure[J].Advances in Clinical Chemistry,2009.163-179.
  • 5急性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,38(3):195-208. 被引量:851
  • 6Swedberg K,Cleland J,Dargie H. Guidelines for the diagnosis and treatment of chronic heart failure:executive summary (update 2005):The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology[J].European Heart Journal,2005,(11):1115-1140.
  • 7Cortés R,Rivera M,Martínez Dolz L. Urinary levels of B-type natriuretic peptide(BNP)and ventricular systolic dysfunction in heart failure patients[J].Revista Clinica Espanola,2009,(04):168-175.
  • 8Cortés R,Rivera M,Salvador A. Urinary B-type natriuretic peptide levels in the diagnosis and prognosis of heart failure[J].Journal of Cardiac Failure,2007,(07):549-555.doi:10.1016/j.cardfail.2007.04.007.
  • 9Palazzuoli A,Gallotta M,Quatrini I. Natriuretic peptides (BNP and NTproBNP):measurement and relevance in heart failure[J].Vasc Health Risk Manage,2010.411-418.
  • 10Liao H,Na MJ,Dikensoy O. Diagnostic value of pleural fluid N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases[J].Respirology,2008,(01):53-57.

二级参考文献39

  • 1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 2中华医学会心血管病学分会 中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用的专家共识[J].中华心血管病杂志,2009,37:195-209.
  • 3中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
  • 4Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416.
  • 5Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442.
  • 6Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure ). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart fa/lure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005, 46: e1-e82.
  • 7Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Aduks: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 2009, 119: 1977-2016.
  • 8Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med, 2008, 36(1 Suppl) : S75-S88.
  • 9Chen D, Assad-Kottner C, Orrego C, et al. Cytokines and acute heart failure. Crit Care Med, 2008, 36(1 Suppl) : S9-S16.
  • 10Chen AA, Wood MJ, Krauser DG, et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J, 2006, 27 : 839-845.

共引文献850

同被引文献31

引证文献4

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部